Title:
PURIFIED POLYPEPTIDES INVOLVED IN GENERAL METABOLISM
Document Type and Number:
WIPO Patent Application WO2003044185
Kind Code:
A3
Abstract:
The present invention relates to polypeptide targets for pathogenic bacteria. The invention also provides biochemical and biophysical characteristics of those polypeptides.
Inventors:
EDWARDS ALED (CA)
DHARAMSI AKIL (CA)
VEDADI MASOUD (CA)
ALAM MUHAMMAD ZAHOOR (CA)
AWREY DONALD (CA)
BEATTIE BRYAN (CA)
CANADIEN VERONICA (CA)
DOMAGALA MEGAN (CA)
HOUSTON SIMON (CA)
MANSOURY KAMRAN (CA)
NECAKOV SASHA (CA)
NETHERY KATHLEEN (CA)
NG IVY (CA)
PINDER BENJAMIN (CA)
SHELDRICK BAY (CA)
VALLEE FRANCOIS (CA)
WREZEL OLGA (CA)
DHARAMSI AKIL (CA)
VEDADI MASOUD (CA)
ALAM MUHAMMAD ZAHOOR (CA)
AWREY DONALD (CA)
BEATTIE BRYAN (CA)
CANADIEN VERONICA (CA)
DOMAGALA MEGAN (CA)
HOUSTON SIMON (CA)
MANSOURY KAMRAN (CA)
NECAKOV SASHA (CA)
NETHERY KATHLEEN (CA)
NG IVY (CA)
PINDER BENJAMIN (CA)
SHELDRICK BAY (CA)
VALLEE FRANCOIS (CA)
WREZEL OLGA (CA)
Application Number:
PCT/CA2002/001768
Publication Date:
August 05, 2004
Filing Date:
November 21, 2002
Export Citation:
Assignee:
AFFINIUM PHARM INC (CA)
EDWARDS ALED (CA)
DHARAMSI AKIL (CA)
VEDADI MASOUD (CA)
ALAM MUHAMMAD ZAHOOR (CA)
AWREY DONALD (CA)
BEATTIE BRYAN (CA)
CANADIEN VERONICA (CA)
DOMAGALA MEGAN (CA)
HOUSTON SIMON (CA)
MANSOURY KAMRAN (CA)
NECAKOV SASHA (CA)
NETHERY KATHLEEN (CA)
NG IVY (CA)
PINDER BENJAMIN (CA)
SHELDRICK BAY (CA)
VALLEE FRANCOIS (CA)
WREZEL OLGA (CA)
EDWARDS ALED (CA)
DHARAMSI AKIL (CA)
VEDADI MASOUD (CA)
ALAM MUHAMMAD ZAHOOR (CA)
AWREY DONALD (CA)
BEATTIE BRYAN (CA)
CANADIEN VERONICA (CA)
DOMAGALA MEGAN (CA)
HOUSTON SIMON (CA)
MANSOURY KAMRAN (CA)
NECAKOV SASHA (CA)
NETHERY KATHLEEN (CA)
NG IVY (CA)
PINDER BENJAMIN (CA)
SHELDRICK BAY (CA)
VALLEE FRANCOIS (CA)
WREZEL OLGA (CA)
International Classes:
C07K14/205; C07K14/21; C07K14/245; C07K14/31; C07K14/315; C12N1/21; C12N9/04; C12N9/10; C12N9/80; (IPC1-7): C12N9/04; C07K1/30; C07K14/205; C07K14/21; C07K14/31; C07K14/315; C07K17/02; C07K19/00; C12N1/21; C12N9/02; C12N9/10; C12N9/80; C12N11/02; C12Q1/26
Domestic Patent References:
WO2001079457A2 | 2001-10-25 | |||
WO2001062688A2 | 2001-08-30 | |||
WO2001073436A1 | 2001-10-04 | |||
WO2001021769A2 | 2001-03-29 |
Foreign References:
EP1158000A1 | 2001-11-28 |
Other References:
DATABASE EMBL [online] XP002268016, retrieved from EBI accession no. EMBL Database accession no. AR149328
OTTING GOTTFRIED: "Experimental NMR techniques for studies of protein-ligand interactions", CURRENT OPINION IN STRUCTURAL BIOLOGY, vol. 3, no. 5, 1993, pages 760 - 768, XP009024400, ISSN: 0959-440X
WHITTLE P J ET AL: "PROTEIN STRUCTURE-BASED DRUG DESIGN", ANNUAL REVIEW OF BIOPHYSICS AND BIOMOLECULAR STRUCTURE, ANNUAL REVIEWS INC., PALO ALTO, CA, US, vol. 23, 1994, pages 349 - 375, XP001008225, ISSN: 1056-8700
OTTING GOTTFRIED: "Experimental NMR techniques for studies of protein-ligand interactions", CURRENT OPINION IN STRUCTURAL BIOLOGY, vol. 3, no. 5, 1993, pages 760 - 768, XP009024400, ISSN: 0959-440X
WHITTLE P J ET AL: "PROTEIN STRUCTURE-BASED DRUG DESIGN", ANNUAL REVIEW OF BIOPHYSICS AND BIOMOLECULAR STRUCTURE, ANNUAL REVIEWS INC., PALO ALTO, CA, US, vol. 23, 1994, pages 349 - 375, XP001008225, ISSN: 1056-8700
Download PDF:
Previous Patent: INTERLEUKIN-2 GENE TRANSFERRED LYMPHOKINE ACTIVATED KILLER CELLS
Next Patent: NOVEL GENE CLUSTER OF PEDERIN BIOSYNTHESIS GENES
Next Patent: NOVEL GENE CLUSTER OF PEDERIN BIOSYNTHESIS GENES